Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma

Clinical trial NCT01649778 · COMPLETED

Trial details

NCT number: NCT01649778
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Renal Cell

Start date: 2012-07-19
Primary completion: 2017-07-03
Enrollment: 662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.